Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. ORIC Pharmaceuticals Inc shares valued at $97,129 were sold by Multani Pratik S on Dec 16 ’25. At $9.06 per share, Multani Pratik S sold 10,720 shares. The insider’s holdings dropped to 68,149 shares worth approximately $0.79 million following the completion of this transaction.
Also, Piscitelli Dominic sold 10,720 shares, netting a total of over 97,127 in proceeds. Following the sale of shares at $9.06 each, the insider now holds 68,148 shares.
Before that, Chacko Jacob had sold 33,374 shares from its account. In a trade valued at $302,368, the PRESIDENT AND CEO traded ORIC Pharmaceuticals Inc shares for $9.06 each. Upon closing the transaction, the insider’s holdings decreased to 33,374 shares, worth approximately $6.7 million.
As published in their initiating research note from Piper Sandler on January 07, 2026, ORIC Pharmaceuticals Inc [ORIC] has been an Overweight and the price target has been revised to $22. Analysts at Evercore ISI started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid November. As of November 18, 2025, Wolfe Research has initiated its “Peer perform” rating for ORIC.
Analyzing ORIC Stock Performance
On last trading session, ORIC Pharmaceuticals Inc [NASDAQ: ORIC] rose 2.40% to $11.52. The stock’s lowest price that day was $11.08, but it reached a high of $11.56 in the same session. During the last five days, there has been a surge of approximately 36.33%. Over the course of the year, ORIC Pharmaceuticals Inc shares have jumped approximately 16.25%.
Support And Resistance Levels for ORIC Pharmaceuticals Inc (ORIC)
RSI (Relative Strength Index) is 72.49 on the 14-day chart, showing overbought technical sentiment.
Is ORIC Pharmaceuticals Inc subject to short interest?
Stocks of ORIC Pharmaceuticals Inc saw a sharp rise in short interest on 2025-12-31 jumping by 3.9 million shares to 21.47 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 17.57 million shares. A jump of 18.18% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 14.98 of the overall float, the days-to-cover ratio (short ratio) jumped to 14.98.
Which companies own the most shares of ORIC Pharmaceuticals Inc (ORIC)?
In terms of ORIC Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 22.5 in the next 12 months, up nearly 100.0% from the previous closing price of $11.25. Analysts anticipate ORIC Pharmaceuticals Inc stock to reach 25 by 2026, with the lowest price target being 18. In spite of this, 5 analysts ranked ORIC Pharmaceuticals Inc stock as Buy at the end of 2026. On July 08, 2025, Ladenburg Thalmann assigned a price target of “a Buy” to the stock and initiated coverage with a $15.
